[HTML][HTML] High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma
MO Ali, S Al Hadidi - Transplantation and Cellular Therapy, 2022 - Elsevier
The use of autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is the
standard of care in patients who are deemed transplantation eligible. Novel therapies …
standard of care in patients who are deemed transplantation eligible. Novel therapies …
High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma
MO Ali, S Al Hadidi - Transplantation and cellular therapy, 2022 - pubmed.ncbi.nlm.nih.gov
The use of autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is the
standard of care in patients who are deemed transplantation eligible. Novel therapies …
standard of care in patients who are deemed transplantation eligible. Novel therapies …
High Dose (Conditioning) Regimens used prior to Autologous Stem Cell Transplantation in Multiple Myeloma.
MO Ali, SA Hadidi - Transplantation and Cellular Therapy, 2022 - europepmc.org
The use of autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is the
standard of care in patients who are deemed transplant eligible. Novel therapies, namely …
standard of care in patients who are deemed transplant eligible. Novel therapies, namely …
[HTML][HTML] High dose (conditioning) regimens used prior to autologous stem cell transplantation in multiple myeloma
MO Ali, S Al Hadidi - … and Cellular Therapy, Official Publication of …, 2022 - astctjournal.org
The use of autologous stem cell transplantation (ASCT) in multiple myeloma (MM) is the
standard of care in patients who are deemed transplantation eligible. Novel therapies …
standard of care in patients who are deemed transplantation eligible. Novel therapies …